compounding

Hims Hers branded GLP-1

Hims & Hers swings to a loss in Q1 amid shift in GLP-1 strategy

Hims & Hers posted a $92 million loss in the first quarter as it transitions its weight loss business away from compounded weight loss drugs.

Heather Landi May 12, 2026 4:00pm

Red computer key with a warning symbol on it

Fierce Pharma

FDA unleashes warning letters to firms selling compounded GLP-1s

Mar 4, 2026 8:30am

Hims Hers Super Bowl commercial

Hims & Hers downplays business impact of compounded GLP-1s

Feb 25, 2026 1:30pm

Weight loss pills Obesity treatment

OpenLoop, Triad Rx sued over 'snake oil' compounded GLP-1

Feb 13, 2026 3:35pm

arrow back backwards u-turn turn around reverse

Fierce Pharma

Hims quits on obesity pill after legal, regulatory heat

Feb 9, 2026 10:24am

Makary

Fierce Pharma

FDA commissioner pledges crackdown on compounding practices

Feb 6, 2026 9:59am